May 31, 2019 — Intelerad Medical Systems announced a $75 million investment in research and development (R&D) to expand its solutions portfolio, with an emphasis on cloud technology and artificial intelligence (AI) solutions.
On a daily basis, Intelerad solutions enable radiologists to perform more than 200,000 diagnostic interpretations worldwide. The company’s $75 million investment and ongoing focus on creating innovative solutions for a global customer base is expected to fuel a twofold increase in study volume. Intelerad technology simplifies everyday tasks for radiologists and other healthcare professionals, enabling them to optimize efficiency and apply their expertise and energy toward more personalized services and follow-ups for every patient.
With an emphasis on cloud technology and AI, Intelerad is focused on providing software-as-a-Service (SaaS) solutions for healthcare. For example, the cloud-based Clairvoyance productivity dashboard will incorporate machine learning technology to provide predictive insights to imaging departments, enabling real-time, data-driven decisions that contribute to higher-quality, more timely care and better outcomes for patients.
Over the last three years, Intelerad has expanded its employee base by 30 percent. The company expects to double in size over the next five years with the recruitment of additional subject matter experts and technologists to swiftly bring innovative solutions to market, continue investing in customer satisfaction and grow Intelerad’s presence worldwide.
“I’ve had the pleasure of using Intelerad technology in my daily work for 17 years, the company truly understands the needs of the medical imaging community,” said radiologist Giovanni Artho, M.D., of the McGill University Health Centre (MUHC). “Intelerad solutions are highly versatile, extremely intuitive and constantly evolving to meet the needs of the market. They have a huge impact on efficiency and are critical for streamlining communication between care team members, which enables us to provide the highest quality patient care.”
For more information: www.intelerad.com
September 24, 2026 
